Kazunari Yoshida

Kazunari Yoshida

Auto-generated profile, based on publicly available information

Kazunari Yoshida

Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
RTRyota Tamura
Ryota Tamura
TOTakayuki Ohira
Takayuki Ohira
KEKatsura Emoto
Katsura Emoto
HFHirokazu Fujiwara
Hirokazu Fujiwara
THTomo Horikoshi
Tomo Horikoshi
KYKazunari Yoshida
Kazunari Yoshida

12 May 2011 in Brain Tumor Pathology
Verified
Journal Article
Closed access
PDF file
SSSatoka Shidoh
Satoka Shidoh
KYKazunari Yoshida
Kazunari Yoshida
KSKatsuya Saitoh
Katsuya Saitoh
TKTokuhiro Kimura
Tokuhiro Kimura
YHYuichiro Hayashi
Yuichiro Hayashi
TKTakeshi Kawase
Takeshi Kawase

11 July 2014 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
KSKatsuya Saito
Katsuya Saito
YIYukihiko Iizuka
Yukihiko Iizuka
SOShigeki Ohta
Shigeki Ohta
STSatoshi Takahashi
Satoshi Takahashi
KNKenta Nakamura
Kenta Nakamura
MTMasahiro Toda
Masahiro Toda
A cDNA library made from 2 glioma cell lines, U87MG and T98G, was screened by serological identification of antigens by recombinant cDNA expression (SEREX) using serum from a glioblastoma patient. Elongation factor Tu GTP binding domain containing protein 1 (EFTUD1), which is required for ribosome biogenesis, was identified. A cancer microarray database showed overexpression of EFTUD1 in gliomas, suggesting that EFTUD1 is a candidate molecular target for gliomas. EFTUD1 expression in glioma cell lines and glioma tissue was assessed by Western blot, quantitative PCR, and immunohistochemistry. The effect on ribosome biogenesis, cell growth, cell cycle, and induction of apoptosis and autophagy in glioma cells during the downregulation of EFTUD1 was investigated. To reveal the role of autophagy, the autophagy-blocker, chloroquine (CQ), was used in glioma cells downregulating EFTUD1. The effect of combining CQ with EFTUD1 inhibition in glioma cells was analyzed. EFTUD1 expression in glioma cell lines and tissue was higher than in normal brain tissue. Downregulating EFTUD1 induced G1 cell-cycle arrest and apoptosis, leading to reduced glioma cell proliferation. The mechanism underlying this antitumor effect was impaired ribosome biogenesis via EFTUD1 inhibition. Additionally, protective autophagy was induced by glioma cells as an adaptive response to EFTUD1 inhibition. The antitumor effect induced by the combined treatment was significantly higher than that of either EFTUD1 inhibition or CQ alone. These results suggest that EFTUD1 represents a novel therapeutic target and that the combination of EFTUD1 inhibition with autophagy blockade may be effective in the treatment of gliomas.

14 February 2020 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
SHShady A. Hassaan
Shady A. Hassaan
RTRyota Tamura
Ryota Tamura
YMYukina Morimoto
Yukina Morimoto
KKKenzo Kosugi
Kenzo Kosugi
MMMohamed Mahmoud
Mohamed Mahmoud
KYKazunari Yoshida
Kazunari Yoshida

1 May 2013 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
HSHirokazu Shido
Hirokazu Shido
YSYoshiaki Sakamoto
Yoshiaki Sakamoto
TMTomoru Miwa
Tomoru Miwa
TOTakayuki Ohira
Takayuki Ohira
KYKazunari Yoshida
Kazunari Yoshida
KKKazuo Kishi
Kazuo Kishi
Cranioplasty using custom-made hydroxyapatite (HAP) ceramic implants is a common procedure for the repair of skull defects. The advantages of using HAP are that it is nonmetallic, unlike titanium; biocompatible; and osteoconductive. Furthermore, it can be molded to any complex shape that may be needed. A disadvantage is that titanium screws and plates are in development for its fixation. We developed a technique for implant fixation using bioabsorbable screws and plates, and named this technique RIVET: resorbable immobilization for vacuolar en bloc technique.Before each operation, the implant was customized for the patient in question on the basis of models prepared using computed tomography data. The bioabsorbable plates were attached to the implant by drilling, tapping, and screwing, as shown in the video (http://links.lww.com/SCS/A43). The interior portion of the screw was then melted to flatten it against the internal surface of the implant, forming a rivet to join the plate and HAP implant.We used this technique for cranial reconstruction in 2 patients, with satisfying and functional results. We did not encounter any complications.In conclusion, the technique described here allows surgeons to fix implants and plates together more rigidly, giving a better result than possible with previous methods.

15 March 2022 in Brain Tumor Pathology
Verified
Journal Article
Closed access
PDF file
EPEriel Sandika Pareira
Eriel Sandika Pareira
MSMakoto Shibuya
Makoto Shibuya
KOKentaro Ohara
Kentaro Ohara
YNYu Nakagawa
Yu Nakagawa
TKTokunori Kanazawa
Tokunori Kanazawa
HSHikaru Sasaki
Hikaru Sasaki